Predictive response-relevant clustering of expression data provides insights into disease processes by Hopcroft, Lisa E. M. et al.
Predictive response-relevant clustering of
expression data provides insights into
disease processes
Lisa E. M. Hopcroft
1, Martin W. McBride
2, Keith J. Harris
1, Amanda K. Sampson
2,
John D. McClure
2, Delyth Graham
2, Graham Young
3, Tessa L. Holyoake
3,
Mark A. Girolami
1,* and Anna F. Dominiczak
2,*
1Inference Group, Department of Computing Science, University of Glasgow, Glasgow G12 8QQ,
2BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place,
Glasgow G12 8TA and
3Paul O’Gorman Leukaemia Research Centre, Section of Experimental
Haematology, Faculty of Medicine, University of Glasgow, Gartnavel General Hospital,
1053 Great Western Road, Glasgow G12 0YN, UK
Received January 27, 2010; Revised May 25, 2010; Accepted May 29, 2010
ABSTRACT
This article describes and illustrates a novel method
of microarray data analysis that couples model-
based clustering and binary classification to form
clusters of ‘response-relevant’ genes; that is,
genes that are informative when discriminating
between the different values of the response.
Predictions are subsequently made using an appro-
priate statistical summary of each gene cluster,
which we call the ‘meta-covariate’ representation
of the cluster, in a probit regression model. We
first illustrate this method by analysing a leukaemia
expression dataset, before focusing closely on the
meta-covariate analysis of a renal gene expression
dataset in a rat model of salt-sensitive hypertension.
We explore the biological insights provided by our
analysis of these data. In particular, we identify a
highly influential cluster of 13 genes—including
three transcription factors (Arntl, Bhlhe41 and
Npas2)—that is implicated as being protective
against hypertension in response to increased
dietary sodium. Functional and canonical pathway
analysis of this cluster using Ingenuity Pathway
Analysis implicated transcriptional activation and
circadian rhythm signalling, respectively. Although
we illustrate our method using only expression
data, the method is applicable to any high-
dimensional datasets. Expression data are available
at ArrayExpress (accession number E-MEXP-2514)
and code is available at http://www.dcs.gla.ac
.uk/inference/metacovariateanalysis/.
INTRODUCTION
Microarray experiments allow the simultaneous expres-
sion measurements of tens of thousands of genes in a bio-
logical sample and have been employed extensively to
investigate human disease since the early 90s (1). Despite
almost two decades of research, challenges regarding the
analysis of these data remain. Typically, the number of
variables (or probes) measured vastly outnumbers the
number of replicate experiments: over 30000 probes
might be measured in only three or four samples,
making good predictive performance possible by chance,
irrespective of whether the data contain relevant patterns.
In addition, many variables will exhibit similar patterns
across the samples; we require methods that identify which
of these correlations are the result of genuine functional
relationships and/or co-regulation and which are merely
observed by chance. Taken together, these features make
microarray analysis statistically demanding, prone to vari-
ability in model parameter estimates and ultimately sus-
ceptible to inaccurate prediction.
Our meta-covariate method is a novel approach to
analysing microarray data, which overcomes and, in the
case of correlated expression patterns, exploits the statis-
tical properties of gene expression data, with a view
to improving prediction and identifying biologically
relevant structure in the data (2). It is, however, applicable
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sequencing and miRNA datasets) where informative cor-
relations exist between the variables. Initially, the D
probes are grouped into K clusters, using gene expression
similarity across the N samples and a standard Gaussian
mixture model. An N-dimensional meta-covariate vector
is then generated from each cluster and predictions
are made by weighting these meta-covariates in a probit
regression model. We then take the novel step of using
the prediction performance to update the clustering struc-
ture, the meta-covariates and the regression weights.
This iterative procedure is repeated until convergence
(Figure 1).
The approach of reducing microarray data
dimensionality by forming clusters (independent of predic-
tions) and making subsequent predictions using cluster
summaries has been adopted previously by Hanczar
et al. (3) and Park et al. (4) amongst others. Where our
method improves upon existing methods is that
inter-predictor correlations are coupled with predictor-
outcome correlations to inform the clustering structure,
the cluster summaries (meta-covariates) and the regression
weights (indicated by the turquoise arrow in Figure 1).
The advantages of our method are three-fold. First,
the clustering component of the model identiﬁes
response-relevant structure in the data, aiding biological
interpretation. Second, the regression coefﬁcients allow
the identiﬁcation of inﬂuential clusters: the greater the
weight assigned to a cluster in the regression model, the
more ‘informative’ that cluster is when discriminating
between the outcomes of the response variable. And
ﬁnally, using the predictor-response correlations to
ﬁne-tune the clustering structure in the model potentially
improves prediction performance.
In this article, we will ﬁrst demonstrate how the
meta-covariate method works using the well-known leu-
kaemia dataset described by Golub et al. (5). We will then
employ the method to analyse gene expression data in the
rat kidney to investigate the genetics of salt-sensitive
hypertension.
MATERIALS AND METHODS
Leukaemia data
In the Golub et al. (5) dataset, bone marrow or peripheral
blood samples were taken from 25 acute myeloid leukae-
mia (AML) and 47 acute lymphoid leukaemia (ALL)
patients. The training data contain 38 samples, of which
11 are AML and 27 are ALL samples. The test data
contain 34 samples, of which 14 are AML and 20 are
ALL. RNA extracted from these samples was tagged
and subsequently hybridized to a high-density
Affymetrix oligoneuclotide microarray (Hu6800/
HuGeneFL). The expression data were obtained from
the Broad Institute Website and pre-processed as recom-
mended in Dudoit et al. (6) (see Supplementary Data for
details), leaving 3571 probes for analysis.
Animal strains
Inbred colonies of SHRSP and WKY have been main-
tained at the University of Glasgow since 1991, as previ-
ously described (7). From weaning, all rats were
maintained on normal rat chow (rat and mouse No.1
maintenance diet, Special Diet Services) and at 18 weeks
of age rats were given a salt challenge (1% NaCl in
drinking water) for 3 weeks.
The congenic strain SP.WKYGla2a (D2Rat13-
D2Rat157) was generated using a marker-assisted
‘speed’ congenic strategy (8) where a WKY (donor
strain) segment was introgressed into the SHRSP (recipi-
ent strain) genetic background.
Microarray data analysis Affymetrix Rat 230-2
Affymetrix GeneChip renal expression analysis was used
to identify differentially expressed probe sets (representing
Figure 1. The meta-covariate method. Expression data are used to form clusters of probes (clustering is represented by the D K matrix of
responsibilities  ). N-dimensional meta-covariates (hk) are calculated from these clusters and used to make predictions in a probit regression
model (with regression coefﬁcients w). The novelty of our method is highlighted in turquoise: the prediction performance is used to update  , hk
and w, thereby iteratively improving the cluster structure and the prediction performance.
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Affymetrix GeneChip) between male, 21-week old,
age-matched salt-loaded and non-treated SHRSP,
SP.WKYGla2a, and WKY rats. Whole kidneys (har-
vested between 10 a.m. and 12 noon and snap-frozen in
liquid nitrogen) were homogenized and total RNA ex-
tracted from three rats from each strain by using the
maxi RNeasy kit according to the manufacturers
protocol (Qiagen). Biotinylated ampliﬁed target cRNA
was prepared and hybridized to the Affymetrix Rat
Rat230-2 gene chips as described by Affymetrix. After
hybridization, microarray chips were washed, stained
and scanned. The microarray data were normalized in R
using RMA (9). To assess the statistical signiﬁcance of
pairwise intergroup differences, Rank products (RP) (10)
was used, corrected for multiple testing using a false dis-
covery rate of 5% (11). The microarray dataset has been
submitted to ArrayExpress (Accession Number
E-MEXP-2514).
Quantitative real-time polymerase chain reaction
Renal total RNA was extracted from 21-week-old
salt-loaded and non-treated male rats using RNeasy kits
(Qiagen), treated with DNase-Free RNase (Ambion), and
accurately quantiﬁed. qRT–PCR was performed using
Taqman (Applied Biosystem, UK) Actb ( -actin)
labelled Vic, as a normalization control and either Arntl
(Rn00577590_m1), Npas2 (Rn01438224_m1), Nﬁl3
(Rn01434874_s1) and Bhlhe41 (Rn00591084_m1) labeled
FAM. Arntl, Npas2, Nﬁl3 and Bhlhe41 were normalized to
Actb, expressed relative to SHRSP (non-salt treated) in
each sample using the comparative (CT) method.
Description of method
As described in the ‘Introduction’ section, the novelty of
this method lies in the coupling of the clustering and pre-
diction components (as depicted by the turquoise arrow in
Figure 1). These components are coupled by optimising all
the parameters (i.e. the parameters pertaining to both
components) simultaneously, rather than optimising the
clustering parameters before the prediction parameters.
Here, we have chosen a Gaussian mixture model as the
clustering model (12, Section 9.2) and probit regression
(12, Section 4.3.5) as the prediction method. We optimize
the parameters of these models using the Expectation-
Maximisation (EM) algorithm (12, Section 9.4), which
ﬁnds the most likely parameter estimates in a probabilistic
model by updating them over a number of iterations. Our
model updates are derived by merging the standard EM
updates for the clustering and regression parameters.
Intuitively, the meta-covariate model can be thought of
as follows: (A) all probes on the array are clustered into K
groups, and each group is then represented by some
average of its members; (B) these cluster averages (which
we call the ‘meta-covariates’) are then used to predict the
response by assigning each meta-covariate a weight in a
regression model; (C) we update the cluster structure (Step
A) and the regression weights (Step B) depending on how
well the meta-covariate regression model predicts the
response. It is also important to appreciate that this
method can be used as an exploratory tool as well as a
prediction algorithm.
The signiﬁcant parameters in this model are  , p, ,  
and w. w is a vector, containing the weights assigned to
each meta-covariate (and therefore each cluster) in the
regression model. Each value in w indicates how much
inﬂuence each cluster has in determining the value of the
response and therefore how informative it is when
discriminating between different values of the response
(in the hypertension dataset, the response is salt-loaded
or non-salt-loaded, while in the leukaemia dataset, the
response is AML or ALL). The other four parameters
are relevant to the clustering model.   is a matrix contain-
ing the meta-covariate representations of the clusters and
 is a matrix that describes the variance within each
cluster in the model; i.e. hk and k ¼ diagð 2
k1,:::, 2
kNÞ are
the mean and covariance of the k-th cluster. p is a vector
containing the proportion of probes in the dataset that are
assigned to each cluster, which are the ‘mixing coefﬁ-
cients’.   is a matrix containing the ‘responsibilities’ that
each cluster k takes for explaining each probe; each
element of   can be interpreted as the probability that a
particular probe belongs to a particular cluster (the  
values for any probe will sum to 1). To generate assign-
ments, a probe is assigned to the cluster to which it has the
highest probability of belonging. Using such ‘soft’ cluster-
ing (rather than ‘hard’ clustering, where each probe is
assigned to a cluster with a probability of 1), aids the in-
terpretation of the model.
Our EM procedure iteratively updates the values of p,  ,
,   and w (and others, see Supplementary Data) until the
model converges. More speciﬁcally, given some number of
clusters K, the goal is to maximise the log joint distribu-
tion with respect to the parameters, p,  , ,   and w, until
the model converges. Here, the convergence criterion is an
increase in the log joint distribution of  0:00001 or some
maximum number of iterations. Note that the value of K
must be set before optimisation, necessitating a model
selection step that identiﬁes which K is best for a given
dataset.
Full details of our method are given in the
Supplementary Data, Sections 1.2–1.3 and MATLAB
code is available at http://www.dcs.gla.ac.uk/inference/
metacovariateanalysis/.
Mapping and ingenuity pathway functional analyses
All probe to gene mappings; gene to pathway mappings
and network analysis tools were taken from Ingenuity
Pathway Analysis software (IPA, http://www.ingenuity
.com/) as of October 2009. Molecular interactions
between genes were mapped to a common pathway
using the Pathway Explorer function within IPA software.
RESULTS AND DISCUSSION
A well-established leukaemia dataset containing expres-
sion data for AML and ALL was used initially to illustrate
our method (2). Our method was then applied to a novel
dataset of renal gene expression data with a view to
providing insight into salt-sensitive hypertension.
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n
where n gives the ID of that cluster in the dataset D
(D 2f leuk, saltg) where leuk denotes the Golub et al.
dataset and salt denotes the hypertension dataset.
The leukaemia data analysis
Leukaemia is a broad term to describe cancer of the blood
or bone marrow. Haemopoiesis, the process of blood pro-
duction, is organized hierarchically with the haemopoietic
stem cell at the apex. The ﬁrst major lineage diversion is
between myeloid and lymphoid progenitors. In AML
there is a block to differentiation with a rapid accumula-
tion of abnormally proliferating myeloid blasts. This
process is mirrored in ALL, but in this case, the blasts
are of lymphoid morphology (13, Chapter 12).
In 1999, Golub et al. published work in which previous-
ly unseen samples could be classiﬁed according to their
gene expression proﬁles; using a weighted vote of 50
probes, they successfully classiﬁed all but one of the
samples in the test set of 34 samples (14 AML and 20
ALL samples). This dataset has been subject to extensive
analysis in the past decade and predictions made from
these data are consistently of good quality, regardless of
the approach taken: using a sparse Bayesian classiﬁcation
model, Bae and Mallick (14) misclassiﬁed two test
samples; Lee and Lee (15) used support vector machines
to analyse an extended multinomial version of the Golub
et al. dataset and achieved a misclassiﬁcation rate of 1;
Tibshirani et al. (16) used the nearest shrunken centroids
and misclassiﬁed two samples; and using a hierarchical
Bayesian model, Lee et al. (17) misclassiﬁed only one
sample.
Although AML and ALL are both forms of leukaemia,
they cause accumulation of different types of cell (5). As
such, there will be many differences between the two sets
of samples in this dataset that are attributable to cell type,
rather than the molecular pathology of the two diseases.
These cellular differences may be responsible for the ease
with which the AML and ALL samples are discriminated
in the literature. It must also be noted that there are
subtypes of AML and ALL (18)—in the process of
haemopoiesis, myeloid and lymphoid progenitor cells
give rise to further cell lineages, where subtypes of AML
and ALL describe cancers exhibiting variable levels of dif-
ferentiation towards mature myeloid and lymphoid cells—
and that the Golub et al. dataset pools all AML and ALL
subtypes together. In addition to the heterogeneity
inherent in the disease, the samples in the dataset vary
with respect to the age of the patient and with respect to
sample type (e.g. both bone marrow aspirates and periph-
eral blood mononuclear samples are used). As such, we
expect that any biology captured by our model would rep-
resent very ‘general’ characterizations of myeloid and
lymphoid cells.
The meta-covariate analysis of the leukaemia data
The Golub data were pre-ﬁltered as described by Dudoit
et al. (6). In our representation, AML samples have been
encoded as 1 and ALL samples have been encoded as 0;
therefore, positively weighted clusters are predictive of
AML samples (these clusters will be described as
AML+) and negatively weighted clusters are predictive
of ALL (such clusters will be described as ALL+). A
model selection step identiﬁed K ¼ 22 as the best model
using the criterion of minimum average test error (the
model selection step performed 1000 iterations of the
EM algorithm, where 2 < K < 50).
The maximum a posteriori (MAP; 12, pp. 30) solution
for this model discriminates perfectly between AML and
ALL samples, in both the training and test set, providing
evidence that our meta-covariate model is able to make
good predictions and suggesting that the clusters formed
are response relevant and, therefore, potentially biologic-
ally relevant.
Cluster morphology. The meta-covariate model algorithm
was run to convergence—the criterion being a difference
in the joint posterior of <0:0001 or a maximum of 5000
iterations—on the leukaemia data, partitioning the probes
into 22 clusters. These clusters and their associated regres-
sion coefﬁcients (w), dataset proportion ( ) and mean
variance ( 2, the variance in expression of cluster
members, averaged over samples) are described in
Table 1. There is a marginal trend for jwkj to decrease
with cluster size (  ¼  0:37, P ¼ 0:09). However, there
is a signiﬁcant correlation between the mean variance in
the cluster and its inﬂuence (  ¼ 0:54, P ¼ 0:01). This is
perhaps contrary to expectation. It might be expected that
the most inﬂuential clusters would identify transcription-
ally tight clusters of genes corresponding to speciﬁc
sub-functionality; however, the opposite is true: the
more inﬂuential clusters are more variable.
This can be explained by considering how hk is
calculated (see Equation 4 in the Supplementary Data).
Table 1. The 22 clusters obtained by meta-covariate analysis of the
leukaemia data [clusters are ordered by absðwÞ]
Cluster Probes w    2
10 62  5.32 1.79 10
 2 7.34 10
 1
12 96 2.55 2.70 10
 2 6.69 10
 1
21 177 2.43 4.93 10
 2 3.94 10
 1
14 214  2.30 5.95 10
 2 2.10 10
 1
5 142 2.17 3.96 10
 2 2.59 10
 1
19 37  1.91 1.06 10
 2 4.88 10
 1
22 124 1.73 3.49 10
 2 9.13 10
 1
3 179  1.71 5.02 10
 2 1.18 10
 1
4 190  1.65 5.42 10
 2 2.37 10
 1
8 263 1.25 7.33 10
 2 1.31 10
 1
15 143 1.04 3.99 10
 2 2.39 10
 1
1 75 1.00 2.12 10
 2 1.92 10
 1
75 2  0.85 1.45 10
 2 2.68 10
 1
16 339  0.79 9.54 10
 2 2.99 10
 1
11 111 0.56 3.09 10
 2 6.57 10
 1
20 162 0.53 4.50 10
 2 1.72 10
 1
13 202 0.50 5.62 10
 2 1.42 10
 1
2 191  0.30 5.35 10
 2 2.61 10
 1
9 210  0.27 5.78 10
 2 2.16 10
 1
18 265  0.17 7.48 10
 2 1.45 10
 1
6 98 0.15 2.71 10
 2 2.88 10
 1
17 239  0.04 6.69 10
 2 1.12 10
 1
w is the regression coefﬁcient of the cluster,   is the size of the cluster
(as a percentage of the whole dataset),  2 is the mean variance of the
cluster.
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which describes how well the current classiﬁcation model
matches the response data, and a standard clustering com-
ponent (12, Section 9.2.2). As the cluster size decreases,
that is, as ck becomes more sparse (where ck is the vector
of clustering responsibilities for cluster k), the model
mismatch terms will dominate the calculation of hk as
the standard clustering component, dependent on ck, will
diminish. Conversely, as the cluster becomes larger and ck
becomes less sparse, the standard mixture modelling com-
ponent will dominate the calculation. Furthermore, as the
cluster becomes more inﬂuential and the value of jwkj in-
creases, the model mismatch term will dominate further.
Therefore, the model will tend to form smaller, inﬂuential,
more variable clusters and larger, less inﬂuential and less
variable clusters, thereby automatically inducing sparsity
in the model.
Capturing large-scale, biological functionality. The model
is capable of capturing large-scale biological functionality
that is of relevance to the response. As expected, the
biology captured by the most inﬂuential clusters in this
dataset describes functions characteristic of myeloid and
lymphoid cells.
Cleuk
10 is the most inﬂuential cluster in the model
generated from the leukaemia data (Figure 2a). The ex-
pression of the genes in this cluster is associated with ALL
samples. Cleuk
10 is enriched for elements in the ‘MIF regu-
lation of innate immunity’ pathway, due to the inclusion
of MIF and its cell surface receptor CD74 (19) in the
cluster (Supplementary Figure S2). MIF is a lymphokine,
a signalling molecule expressed by lymphocytes
(http://www.ncbi.nlm.nih.gov/gene/4282), which has
been shown to play a role in T-cell tumourigenesis (20)
and lymphocyte proliferation (21,22). CD74 is expressed
on malignant B cells (a form of lymphoid cell), but is ex-
pressed to a much lesser extent on non-malignant cell
surfaces stein (23) (Supplementary Figure S3).
Cleuk
12 is the most inﬂuential AML+cluster (Figure 2b).
The most over-represented IPA pathway in this cluster is
the ‘triggering receptor expression on myeloid cells 1’ (or
TREM1) signalling pathway (Supplementary Figure S4).
TREM1 activation has various roles in both the adaptive
and innate immune response, but critically, it is only ex-
pressed in myeloid cells (Supplementary Figure S5). This
cluster is also enriched for ‘acute myeloid leukaemia
signalling’ proteins; in fact, the top ﬁve AML+ clusters
(Cleuk
12 ,C leuk
21 ,C leuk
5 ,C leuk
22 and Cleuk
8 ) are all enriched for
this pathway (Supplementary Figure S6). This IPA canon-
ical pathway describes the signalling pathways which,
when disrupted by abnormalities (e.g. mutations to
genes and/or transcription factors), can lead to increased
proliferation and apoptosis resistance in AML. These two
pathways are myeloid-speciﬁc, describing processes that
occur exclusively in myeloid cells.
Clusters can also represent more speciﬁc, biological sub-
functionality. The predictive ability of each cluster only
exists within the meta-covariate model. Although some
clusters may clearly discriminate between AML and
ALL samples, others may be good at predicting
subtypes of either disease. ALL samples can be further
sub-classiﬁed as T- or B-cell ALL. Cleuk
19 is an example of
one of these ‘subtype speciﬁc’ clusters. It is ALL+, with a
regression coefﬁcient of  1.91. From the expression plot
in Figure 2c, it is clear that this cluster is important when
classifying speciﬁcally T-cell ALL samples: expression in
these samples is visibly higher, while expression in the
B-cell ALL and AML samples is similarly low. This
cluster is enriched for several T-cell lymphocyte-speciﬁc
canonical pathways, including the ‘Calcium-induced T
lymphocyte apoptosis’; ‘iCOS-iCOSL’ and ‘CD28
Signalling in T Helper Cells’; ‘cytotoxic T lymphocyte-
mediated apoptosis of target cells’ and ‘T cell receptor
signalling’ IPA canonical pathways (Supplementary
Figure S7).
Figure 2. Expression, mean expression ( ) and hk vectors for three clusters generated by the meta-covariate method, when analysing the leukaemia
data. (a) ALL+C
leuk
10 ðw ¼  5:32Þ;( b) AML+C
leuk
12 ðw ¼ 2:55Þ and (c) ALL+C
leuk
19 ðw ¼  1:91Þ. Extended versions with sample IDs are available in
Supplementary Figures S14–S16.
Nucleic Acids Research, 2010,Vol.38, No. 20 6835Sub-type-speciﬁc clusters can arise in our model because
complementary clusters, which are able to predict the
other subtype(s) within a class, can exist. An example of
a complementary cluster to Cleuk
19 is Cleuk
14 (Supplementary
Figure S8); here, the cluster contains genes that are more
highly expressed in B-cell ALL samples than T-cell ALL
and AML samples.
Applying our meta-covariate method to novel renal,
gene expression data
In the previous section, we illustrated the use of our
meta-covariate method by applying it to a well-known
leukaemia dataset. We observed that the inﬂuential
clusters tend to be smaller and more variable than the
less inﬂuential clusters and that the model is able to
capture both large-scale biological characteristics and
small-scale, more speciﬁc biological characteristics. In
the next section, our method is applied to a dataset of
renal gene expression proﬁles in a rat model of salt-
sensitive hypertension.
The hypertension data analysis
Essential hypertension (chronically elevated blood
pressure) is a genetically complex disease, currently affect-
ing one quarter of adults worldwide and projected to
affect almost 30% of adults within 15 years (24). One
half of hypertensive patients are salt sensitive, exhibiting
increased blood pressure with increased dietary sodium
(25). Elucidating the genetics of hypertension would
have far-reaching implications for global health. Animal
models are useful functional models allowing the genetic
dissection of complex, polygenic disease; the data
described here are derived from a rat model of
salt-sensitive hypertension (26).
The SHRSP, Wistar-Kyoto (WKY) and congenic
SP.WKYGla2a strains of rat are distinct with respect to
phenotype in response to salt, with the SHRSP
demonstrating increased systolic blood pressure and circa-
dian amplitude in response to salt, the WKY being largely
unaffected by salt, and the SP.WKYGla2a demonstrating
an intermediate increase in both systolic blood pressure
and circadian amplitude in response to salt (27,
Supplementary Figure S9).
Microarray experiments were conducted to measure
renal gene expression in male, age-matched, 21-week-old
salt-loaded and non-salt-loaded animals. The resulting
dataset was analysed using our meta-covariate method.
Genes contained in inﬂuential clusters will be informative
when discriminating between salt-loaded samples and
non-salt-loaded samples. Furthermore, identifying gene
expression changes between SP.WKYGla2a and SHRSP
will highlight chromosome 2-dependent processes
involved in blood pressure regulation.
The sample size (n=18) is small; as such, we used all the
data to build the model, rather than making predictions
on a test set. However, here we can demonstrate the
second use of our method, by employing it as a valuable
supervised clustering tool to generate response-relevant
clusters within the given dataset, rather than using it
primarily to build a classiﬁer (as demonstrated in the
previous section when analysing the leukaemia data).
The 4562 probes on the array were identiﬁed as signiﬁ-
cant using the Wilcoxon rank-sum test (P   0:05). K was
set to 20, following 1000 iterations of the method for each
value of K where 2 < K < 50, and subsequent analysis
using Bayesian information criterion (BIC); for K ¼ 20,
BIC=85731. BIC is a regularized model selection tech-
nique, which identiﬁes the most likely values of the model
parameters, whilst penalising unnecessary model com-
plexity (12, Section 4.4.1). Upon completion, the
meta-covariate model successfully partitioned the dataset
with respect to salt.
Cluster morphology. The 20 clusters that are formed are
described in Table 2. Here, there is an imbalance of posi-
tively and negatively weighted clusters—12 negative to 8
positive—unlike in the leukaemia model (Table 1), where
there were equal numbers of positively and negatively
weighted clusters.
This model is dominated by heavily, negatively
weighted clusters: the three most inﬂuential clusters
(Csalt
13 , w ¼  46:76; Csalt
8 , w ¼  9:59; Csalt
5 , w ¼  7:13)
are all negatively weighted (note also that these three
clusters have similar variance). This suggests the
dominant biology captured by this model is reduced ex-
pression in the salt-loaded animals. That is, the biology
that contributes most signiﬁcantly to the discrimination
between the salt-loaded and non-salt-loaded samples is
that of lower expression in the salt-loaded samples.
Cluster size is signiﬁcantly inversely correlated with re-
gression weight (  ¼  0:46, P ¼ 0:04) and signiﬁcantly
correlated with average variance (  ¼ 0:67, P < 0:01).
Therefore, as observed in the leukaemia dataset, the
method has generated both small, variable (with respect
Table 2. The 20 clusters obtained by meta-covariate analysis of the
salt data [clusters are ordered by absðwÞ]
Cluster Probes w    2
13 13  46.76 2.71 10
 3 2.27 10
 1
87  9.59 1.51 10
 3 2.26 10
 1
51 4  7.13 3.14 10
 3 2.33 10
 1
3 70 4.27 1.54 10 
2 5.59 10
 2
15 301  3.32 6.61 10
 2 2.37 10
 2
6 317  3.08 6.96 10
 2 2.31 10
 2
14 284  2.69 6.23 10
 2 2.51 10
 2
2 408 2.65 8.95 10
 2 1.52 10
 2
16 329 2.02 7.19 10
 2 1.95 10
 2
4 454 1.85 9.95 10
 2 1.58 10
 2
19 28  1.54 6.18 10
 3 1.13 10
 1
17 336  1.44 7.29 10
 2 2.13 10
 2
10 361 1.35 7.93 10
 2 2.05 10
 2
1 163 1.00 3.62 10
 2 3.07 10
 2
7 316  0.88 6.91 10
 2 2.29 10
 2
11 231 0.82 5.07 10
 2 2.46 10
 2
20 90 0.80 1.96 10
 2 4.53 10
 2
9 310  0.58 6.85 10
 2 2.24 10
 2
12 282  0.28 6.15 10
 2 2.38 10
 2
18 248  0.10 5.45 10
 2 2.09 10
 2
w is the regression coefﬁcient of the cluster,   is the size of the cluster
(as a percentage of the whole dataset),  2 is the mean variance of the
cluster.
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tight, non-inﬂuential clusters.
This feature of our model is particularly useful in this
dataset, where all of the 4562 probes are signiﬁcantly
correlated with the response. The induced sparsity
allows identiﬁcation of the most relevant features, in a
congested dataset where all features are relevant by trad-
itional, univariate methods. Furthermore, there is no cor-
relation between the Wilcoxon P-value and regression
coefﬁcient in this dataset (  ¼  1:47   10 3,
P ¼ 9:21   10 1), indicating that the most valuable pre-
dictors (as deﬁned by the meta-covariate model) would
not be selected on the basis of P-value alone.
With a view to establishing (i) how sensitive our method
is to variation in the data and (ii) how robust these clusters
are, we performed leave one out cross-validation
(LOOCV) and compared the models generated from the
LOOCV folds to each other and to the model generated
from the full dataset using two metrics—adjusted rand
index (ARI) (28) and adjusted mutual information
(AMI) (29)—both of which measure concordance
between clustering structures, while accounting for
chance. The results are very encouraging: despite the
small sample size, clustering concordance is high (see
Supplementary Figures S10–S11 and Supplementary
Tables S1–S2). The mean concordance between the clus-
tering structures of the LOOCV-fold models and the clus-
tering structure of the model built from the dataset in its
entirety (i.e. the clustering described in Table 2) is 0.96
( =0.011) and 0.96 ( =0.0070) for the ARI and AMI
metrics, respectively (all values rounded to 2 s.f.). This
convincingly demonstrates that a similar clustering struc-
ture is observed across LOOCV folds and, therefore, that
the method is insensitive to variation in the input data.
This is particularly encouraging given that an initial mo-
tivation for this method was to avoid such sensitivity. We
can now progress with the analysis of these data, with
conﬁdence in the clustering structure.
An inﬂuential cluster of thirteen genes. Csalt
13 is the most
inﬂuential cluster: its regression coefﬁcient is ﬁve times
larger than the second most inﬂuential cluster.
Classiﬁcation using this cluster and its regression coefﬁ-
cient in isolation results in only one misclassiﬁcation (the
SHRSP+salt animal, C3996) using the decision boundary
(y ¼ 0). Although we should be cautious of reading too
much into cluster performance in isolation, given that
clusters are only relevant as part of the model as a
whole, it is a useful indicator of how informative a
cluster is in the model.
The negative regression coefﬁcient indicates that the
genes in this cluster are, largely, more highly expressed
in the non-salt-loaded samples than the salt-loaded
samples, as is evident in the graph of the mean expression
values ( ) in Figure 3. Comparing the mean expression
values to the   values illustrates the effect of incorporating
an outcome-speciﬁc component in the calculation of hk:
the difference between the non-salt-loaded and salt-loaded
samples is exaggerated in the graph of  13 (hk where
k ¼ 13) in Figure 3.
Note that the difference between   and   in the renal
dataset is greater than in the leukaemia dataset
(Figure 2a–c and Supplementary Figure S8). This
suggests that there is greater discriminative power in the
unaltered leukaemia data than in the unaltered hyperten-
sion data. This is not surprising, given the known hetero-
geneity in the leukaemia samples and the comparative
homogeneity of the inbred rats. It is encouraging that
the model is able to use patterns that exist in the mean
gene expression data to build the model, but that it is also
able to alter the cluster representation (i.e. alter  )t oﬁ n d
more complex informative patterns.
Strain-speciﬁc expression of Csalt
13 genes. Figure 4a–c show
the results of a RP analysis (10) within each strain,
between the salt-loaded and non-salt-loaded datasets
(Supplementary Tables S3–S5, chromosome mappings
given in Supplementary Table S6). Most of the genes are
signiﬁcantly differentially expressed between the
salt-loaded and non-salt-loaded datasets in both the
WKY and SP.WKYGla2a (Figure 4a and b, respectively).
However, the same genes are not differentially expressed
when comparing the salt-loaded and non-salt-loaded
SHRSP animals (Figure 4c) giving rise to the hypothesis
that changes in expression levels of the genes in C
salt
13 are
protective against hypertension in response to an increase
in dietary sodium. These results are corroborated by a
Rosetta Resolver analysis (http://www.rosettabio
.com/products/resolver; data not shown) and the differen-
tial expression of the four transcription factors (Arntl,
Figure 3. Expression, mean expression ( ) and hk vectors for
C
salt
13 ðw ¼  46:76Þ, generated by the meta-covariate method when
analysing the hypertension data. Extended version with sample IDs is
given in Supplementary Figure S17.
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PCR (Figure 4d–g, respectively).
Circadian rhythm genes are implicated. Eleven of the
thirteen probes in this cluster were mapped to genes
using IPA. A canonical pathway analysis of these eleven
genes shows that the cluster is enriched for circadian
rhythm signalling genes (Supplementary Figures
S12–S13). This is relevant as all three rat strains demon-
strate circadian patterns of systolic blood pressure: these
nocturnal animals have a higher blood pressure during the
night than during the day and this difference and the cir-
cadian amplitude is exacerbated on salt-loading in the
SHRSP (Supplementary Figure S9).
Identifying a transcriptional network within C
salt
13 . Also
shown in Figure 4a–c are the relationships between the
genes in C
salt
13 , as described in the Ingenuity Pathway
Knowledge Base. Of note are the four transcription
factors, three of which, neuronal PAS domain protein 2
or Npas2 (also known as Bhlhe9); aryl hydrocarbon
receptor nuclear translocator-like or Arntl (also known
as Bmal1 and Bhlhe5); and basic helix–loop–helix family
member e41 Bhlhe41 (also known as Dec2), are known to
form a transcriptional network and, as seen in a previous
section, are potentially protective against hypertension,
being differentially expressed on salt in the
SP.WKYGla2a and WKY strains. These three transcrip-
tion factors are central components of the circadian clock
(Supplementary Figure S12). Aryl hydrocarbon receptor
nuclear translocator-like (Arntl) forms a heterodimer with
Clock and is required for E-box-dependent transactivation
activating the transcription of the Per genes from the
E-box elements in its promoter region (30,31). Protein
products of Per act together with Cry proteins to inhibit
Per transcription, thus closing the autoregulatory
feedback loop. It has been shown that the basic helix–
loop–helix transcription factors (Bhlhe41) can repress
Clock/Bmal1-induced transactivation of the mouse Per1
promoter through direct protein-protein interactions
with Bmal1 and/or competition for E-box elements.
Disruption of the key molecular oscillators (Arntl,
Npas2) and autoregulatory feedback loops (Bhlhe41,
Per, Dbp, Cry), have recently been shown to be involved
in hypertension (32) and salt sensitivity in both mice
(33,34) and rats (35).
Identifying a signiﬁcant transcriptional network. The IPA
network generation algorithm was used to form networks
of genes known to be functionally related, as deﬁned by
the Ingenuity Pathway Knowledge Base. This algorithm
generates small (at most 35 genes), densely connected
networks from a set of ‘focus genes’; IPA is able to ‘ﬁll
in the gaps’ with linker genes to maximise connectivity in
the networks. Constructing networks around the signiﬁ-
cantly differentially expressed genes identiﬁed by RP (10)
in the salt data, we can identify networks of functionally
related genes that are relevant to salt-loaded animals.
The same three transcriptional regulators that form the
transcriptional network in C
salt
13 are present in the most
signiﬁcant networks generated from the SP.WKYGla2a
(P ¼ 1   10 48) and WKY (P ¼ 1   10 46) RP gene
Figure 4. The contents of C
salt
13 overlaid with the salt-loaded comparisons in the (a) WKY (salt/no-salt RP overlay), (b) SP.WKY Gla2a (salt/no-salt
RP overlay) and (c) SHRSP (salt/no-salt RP overlay) animals. Green indicates signiﬁcant down-regulation and red indicates signiﬁcant up-regulation
in the salt dataset. RP-fold change is indicated below each molecule. Direct relationships are indicated by a solid line. qRT–PCR of the four
transcription factors identiﬁed in C
salt
13 conﬁrming signiﬁcant differences in SP.WKYGla2a and WKY salt-loaded animals (ﬁlled) compared to
age-matched animals not exposed to salt (open) for (d) Arntl, (e) Npas,( f) Nﬁl3 and (g) Bhlhe41 (*P<0.05, **P<0.001).
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(Figure 5a–b and Supplementary Tables S7–S8). To
have arrived at a similar conclusion both by way of IPA
network analysis and by our meta-covariate method is
encouraging. Further, our meta-covariate method
identiﬁes a much smaller set of genes, allowing more
concise interpretation of the data.
Further investigation and validation experiments are
underway, with the priority being the elucidation of how
these genes are linked to chromosome 2 and how they are
involved in sodium homeostasis. In addition, a major
focus will be to investigate why the genes in C
salt
13 vary
similarly with the response; this may be due to shared
transcriptional regulation.
CONCLUSION
In this article, we describe and illustrate a novel method of
microarray analysis using the Golub et al. (5) leukaemia
dataset, before applying the same analysis to a novel
dataset of renal gene expression data in rat models of
salt-sensitive hypertension. It was demonstrated that the
prediction performance of our meta-covariate method is
competitive in the Golub et al. dataset. Although we
refrain from drawing any additional conclusions from
these data, beyond the identiﬁcation of general patterns,
we would like to stress that further analysis of these data
could be informative, provided the caveats with respect to
the experimental design are kept in mind.
Although we were not able to evaluate prediction per-
formance in an independent test set given the small size of
the hypertension dataset, the model generated from the
training set was able to perfectly discriminate between
salt-loaded and non-salt-loaded samples. However, it
must also be noted that it is perfectly valid to use the
meta-covariate method as a supervised clustering
technique with a view to identifying response-relevant
gene clusters, as well as a classiﬁcation model.
Both datasets demonstrated that the model tends to
form small, variable, inﬂuential clusters and larger,
tighter, less inﬂuential clusters. This is particularly useful
in a congested, homogeneous dataset, such as the hyper-
tension dataset, where many, if not all, variables are sig-
niﬁcantly correlated with the response. The ﬂexibility of
the model was evident in that discrimination patterns were
identiﬁed in the mean gene expression data where possible,
but where these data were not informative, complex
patterns were identiﬁed by alternative representations of
the clusters.
We are currently developing a fully Bayesian implemen-
tation of this meta-covariate method—which will provide
a range of clustering structures for a dataset rather than a
single clustering scheme—while carrying out further bio-
logical validation of our ﬁndings.
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Supplementary Data available at NAR Online.
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Figure 5. (a) and (b) the most signiﬁcant networks identiﬁed in the salt-loaded/non-salt-loaded data, across the SP.WKYGla2a and WKY strains,
respectively. Red indicates up-regulation in the salt-dataset compared to no-salt treatment, green indicates down-regulation in the dataset, as deﬁned
by RP (10); legend shown above.
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